Medical Physics, AI and Neurotechnology · University of Rome Tor Vergata

fismed@uniroma2.it

FISMED / PROJECTS

CARDIMIRAX

CARDIMIRAX investigates variants of the HAX-1 gene produced through alternative splicing as potential molecular biomarkers for cardiomyopathies. The project explores molecular differences that could help characterize diseases affecting heart muscle.

Completed01/01/2018–01/01/2019research grant

University of Rome Tor Vergata

CARDIMIRAX / HAX-1 splice variants as potential molecular biomarkers for cardiomyopathies

CARDIMIRAX investigates variants of the HAX-1 gene produced through alternative splicing as potential molecular biomarkers for cardiomyopathies. The project explores molecular differences that could help characterize diseases affecting heart muscle.

Co-PI

Project details
Research partners
University of Rome Tor Vergata
Programme
Mission Sustainability
Grant / award ID
CUP E81I18000370005
Total project award€35,000